{"gene":"BCORL1","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2007,"finding":"BCORL1 (BCoR-L1) functions as a transcriptional corepressor that associates with Class II HDACs (HDAC4, HDAC5, HDAC7) as determined by co-precipitation, and interacts with the CtBP corepressor through a CtBP-interacting motif in its amino terminus.","method":"Co-precipitation, reporter assays, RNAi knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-precipitation, reporter assays, and RNAi knockdown with defined endogenous target (E-cadherin), multiple orthogonal methods in a single study","pmids":["17379597"],"is_preprint":false},{"year":2007,"finding":"Abrogation of the CtBP binding site within BCORL1 partially relieves BCORL1-mediated transcriptional repression, demonstrating that CtBP interaction contributes to its repressor function. BCORL1 occupies the E-cadherin promoter and RNAi-mediated knockdown of BCORL1 derepresses E-cadherin in cells that normally silence it.","method":"Mutagenesis of CtBP-interacting motif, reporter assay, RNAi knockdown, ChIP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis combined with reporter assays and endogenous gene derepression by RNAi, multiple orthogonal methods","pmids":["17379597"],"is_preprint":false},{"year":2016,"finding":"BCORL1 forms a heterodimer with PCGF1 and this BCORL1/PCGF1 heterodimer is required for recruitment of the non-canonical Polycomb Repressive Complex PRC1.1 to CpG islands via KDM2B/SKP1. The crystal structure of the KDM2B/SKP1/BCORL1/PCGF1 complex reveals that the BCORL1 PUFD domain positions residues preceding the RAWUL domain of PCGF1 to create an extended interface for KDM2B interaction.","method":"In vitro assembly assays, crystal structure, co-precipitation of subcomplexes","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with in vitro reconstitution of minimal complex and domain-level functional dissection","pmids":["27568929"],"is_preprint":false},{"year":2022,"finding":"Mutations in BCORL1 (and BCOR) in leukemia disrupt assembly of the non-canonical PRC1.1 complex, selectively unlinking the RING-PCGF enzymatic core from the chromatin-targeting auxiliary subcomplex. Mutated PRC1.1 is localized to chromatin but lacks repressive H2A-ubiquitinating activity, leading to epigenetic reprogramming and transcriptional activation at target loci, and conferring acquired resistance to treatment while sensitizing to targeted kinase inhibition.","method":"Biochemical complex assembly assays, chromatin localization studies, transcriptomic analysis of mutant cells and primary patient samples","journal":"Blood cancer discovery","confidence":"High","confidence_rationale":"Tier 2 / Moderate — complex assembly and chromatin localization experiments combined with transcriptomic data in mutant cells and primary samples, multiple orthogonal methods","pmids":["35015684"],"is_preprint":false},{"year":2020,"finding":"Knockout of Bcorl1 in mice results in male infertility with impaired spermatogenesis, reduced sperm motility, and abnormal mitochondrial structure in sperm cells. Knockdown of Bcorl1 in mouse spermatogonial stem cells inhibits their self-renewal in vitro.","method":"CRISPR-Cas9 knockout mice, siRNA knockdown in spermatogonial stem cells","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR knockout mouse model with defined spermatogenic phenotype plus in vitro stem cell knockdown, two orthogonal approaches in one study","pmids":["32376790"],"is_preprint":false},{"year":2024,"finding":"A truncating BCORL1 variant (p.Glu522*) produces a truncated protein with altered cellular localization and a dysfunctional interaction with SKP1 (S-phase kinase-associated protein 1), linking BCORL1 to the SCF ubiquitin ligase complex and to the pathogenesis of oligoasthenoteratozoospermia.","method":"Whole-exome sequencing, functional analysis with recombinant protein, localization assay, co-immunoprecipitation","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — single lab, co-IP and localization data for variant protein, limited replication","pmids":["38342987"],"is_preprint":false},{"year":2024,"finding":"BCORL1 missense variants (p.V872G, p.G1391R) disrupt the interaction between BCORL1 and HDACs, causing epigenetic alterations and interfering with the orderly transcription of spermatogenetic genes, leading to OAT phenotype with acephalic sperm and abnormal acrosome.","method":"In vitro recombinant plasmid functional assays, co-immunoprecipitation, sperm morphology analysis","journal":"Andrology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — single lab with in vitro functional assays and co-IP for HDAC interaction disruption, limited replication","pmids":["39189935"],"is_preprint":false},{"year":2018,"finding":"A missense mutation BCORL1 Q1076H contributes to vemurafenib resistance in melanoma cells; either endogenous BCORL1 silencing or ectopic expression of BCORL1 Q1076H mimics the effects of CRISPR/Cas9-edited BCORL1 Q1076H, suggesting the mutation exerts a complex mixture of loss- and gain-of-function effects confirmed by transcriptomic data.","method":"CRISPR/Cas9 editing, RNAi silencing, ectopic overexpression, transcriptomics","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR editing, RNAi, and ectopic expression with transcriptomic validation, multiple orthogonal methods in single lab","pmids":["29605720"],"is_preprint":false}],"current_model":"BCORL1 is a transcriptional corepressor that functions as a core subunit of the non-canonical Polycomb Repressive Complex PRC1.1: it forms a heterodimer with PCGF1 (via its PUFD domain) that recruits KDM2B/SKP1 to CpG islands for H2A ubiquitination and gene repression; it also associates with Class II HDACs (HDAC4/5/7) and the CtBP corepressor to silence target genes such as E-cadherin; loss-of-function mutations in leukemia unlink the PRC1.1 enzymatic core from its chromatin-targeting module, causing epigenetic reprogramming and oncogenic signaling; and in the germline, BCORL1 is required for spermatogenesis and spermatogonial stem cell self-renewal, with variants disrupting HDAC interaction and SKP1 binding."},"narrative":{"mechanistic_narrative":"BCORL1 is a transcriptional corepressor that silences target genes by coupling chromatin-targeting and histone-modifying machineries [PMID:17379597, PMID:27568929]. It associates with Class II histone deacetylases (HDAC4, HDAC5, HDAC7) and engages the CtBP corepressor through an amino-terminal CtBP-interacting motif; loss of CtBP binding partially relieves its repressive activity, and BCORL1 occupies and silences the E-cadherin promoter such that its depletion derepresses E-cadherin [PMID:17379597]. BCORL1 is a structural subunit of the non-canonical Polycomb Repressive Complex PRC1.1, where its PUFD domain heterodimerizes with PCGF1 to position residues preceding the PCGF1 RAWUL domain and build an extended interface that recruits KDM2B/SKP1 to CpG islands [PMID:27568929]. In leukemia, BCORL1 mutations disrupt PRC1.1 assembly, unlinking the RING-PCGF enzymatic core from the chromatin-targeting subcomplex so that the complex remains chromatin-bound but loses H2A-ubiquitinating activity, driving epigenetic reprogramming and transcriptional activation at target loci [PMID:35015684]. BCORL1 is required for male fertility: its knockout in mice impairs spermatogenesis, reduces sperm motility, and disrupts sperm mitochondrial structure, while knockdown blocks spermatogonial stem cell self-renewal, and human variants causing oligoasthenoteratozoospermia act by disrupting BCORL1 interactions with HDACs or with SKP1 [PMID:32376790, PMID:38342987, PMID:39189935].","teleology":[{"year":2007,"claim":"Established BCORL1's foundational identity as a transcriptional corepressor by defining its protein partners and a direct endogenous target, answering whether it actively silences genes.","evidence":"Co-precipitation with Class II HDACs and CtBP, mutagenesis of the CtBP motif, reporter assays, ChIP, and RNAi-mediated derepression of E-cadherin","pmids":["17379597"],"confidence":"High","gaps":["Did not establish whether HDAC/CtBP association is direct or bridged","Genome-wide target spectrum beyond E-cadherin not defined"]},{"year":2016,"claim":"Defined the structural basis for BCORL1's role in chromatin targeting, showing it is a core PRC1.1 subunit that heterodimerizes with PCGF1 to recruit KDM2B/SKP1 to CpG islands.","evidence":"In vitro complex reconstitution, co-precipitation of subcomplexes, and crystal structure of KDM2B/SKP1/BCORL1/PCGF1","pmids":["27568929"],"confidence":"High","gaps":["Did not address how this module connects to the catalytic RING-PCGF core in cells","In vivo CpG island occupancy not mapped"]},{"year":2018,"claim":"Connected BCORL1 alteration to therapy resistance, showing a missense mutation modulates melanoma vemurafenib resistance through mixed loss- and gain-of-function effects.","evidence":"CRISPR/Cas9 editing, RNAi silencing, ectopic overexpression, and transcriptomics in melanoma cells","pmids":["29605720"],"confidence":"Medium","gaps":["Molecular mechanism linking the Q1076H mutation to resistance not resolved","Whether effect operates through PRC1.1 or HDAC pathways unclear"]},{"year":2020,"claim":"Revealed an in vivo physiological requirement for BCORL1 in male germline development, beyond its biochemical corepressor roles.","evidence":"CRISPR-Cas9 knockout mice with spermatogenic phenotyping and siRNA knockdown in spermatogonial stem cells","pmids":["32376790"],"confidence":"High","gaps":["Transcriptional targets driving the spermatogenesis defect not identified","Link between corepressor activity and mitochondrial sperm phenotype unexplained"]},{"year":2022,"claim":"Resolved the mechanism by which leukemia mutations corrupt PRC1.1, showing they uncouple the enzymatic core from chromatin targeting while preserving chromatin localization.","evidence":"Biochemical complex assembly and chromatin localization assays plus transcriptomics of mutant cells and primary patient samples","pmids":["35015684"],"confidence":"High","gaps":["Specific oncogenic target loci driving transformation not fully enumerated","Mechanism of acquired drug resistance and kinase-inhibitor sensitization not mechanistically dissected"]},{"year":2024,"claim":"Connected specific human BCORL1 variants to oligoasthenoteratozoospermia by demonstrating disrupted SKP1 and HDAC interactions, tying germline pathology to its corepressor and SCF-linked interactions.","evidence":"Whole-exome sequencing, recombinant protein functional assays, localization assays, co-immunoprecipitation, and sperm morphology analysis","pmids":["38342987","39189935"],"confidence":"Medium","gaps":["Single-lab co-IP data without reciprocal validation","Causal link from interaction loss to specific sperm phenotypes not established in vivo"]},{"year":null,"claim":"How BCORL1's corepressor functions (HDAC/CtBP association versus PRC1.1 assembly) are differentially deployed across tissues and which downstream gene programs they control in the germline remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Genome-wide direct target catalog across cell types unknown","Relative contributions of PRC1.1 versus HDAC/CtBP pathways to spermatogenesis undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[4]}],"complexes":["PRC1.1 (non-canonical PRC1)"],"partners":["PCGF1","KDM2B","SKP1","HDAC4","HDAC5","HDAC7","CTBP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q5H9F3","full_name":"BCL-6 corepressor-like protein 1","aliases":[],"length_aa":1785,"mass_kda":190.6,"function":"Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence-specific DNA-binding proteins such as BCL6. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q5H9F3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BCORL1","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/BCORL1","total_profiled":1310},"omim":[{"mim_id":"617543","title":"POLYCOMB GROUP RING FINGER PROTEIN 3; PCGF3","url":"https://www.omim.org/entry/617543"},{"mim_id":"610231","title":"POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1","url":"https://www.omim.org/entry/610231"},{"mim_id":"301029","title":"SHUKLA-VERNON SYNDROME; SHUVER","url":"https://www.omim.org/entry/301029"},{"mim_id":"300688","title":"BCL6 COREPRESSOR-LIKE 1; BCORL1","url":"https://www.omim.org/entry/300688"},{"mim_id":"300608","title":"DACHSHUND FAMILY TRANSCRIPTION FACTOR 2; DACH2","url":"https://www.omim.org/entry/300608"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BCORL1"},"hgnc":{"alias_symbol":["FLJ11362","BCoR-L1"],"prev_symbol":["CXorf10"]},"alphafold":{"accession":"Q5H9F3","domains":[{"cath_id":"1.25.40.20","chopping":"1429-1550_1559-1577","consensus_level":"medium","plddt":78.1621,"start":1429,"end":1577},{"cath_id":"3.10.260.40","chopping":"1595-1668_1683-1711","consensus_level":"medium","plddt":74.093,"start":1595,"end":1711}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5H9F3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5H9F3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5H9F3-F1-predicted_aligned_error_v6.png","plddt_mean":38.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCORL1","jax_strain_url":"https://www.jax.org/strain/search?query=BCORL1"},"sequence":{"accession":"Q5H9F3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5H9F3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5H9F3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5H9F3"}},"corpus_meta":[{"pmid":"24047651","id":"PMC_24047651","title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24047651","citation_count":173,"is_preprint":false},{"pmid":"17379597","id":"PMC_17379597","title":"A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17379597","citation_count":72,"is_preprint":false},{"pmid":"21989985","id":"PMC_21989985","title":"Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21989985","citation_count":60,"is_preprint":false},{"pmid":"27537276","id":"PMC_27537276","title":"Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.","date":"2016","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27537276","citation_count":57,"is_preprint":false},{"pmid":"27568929","id":"PMC_27568929","title":"KDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1.","date":"2016","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/27568929","citation_count":50,"is_preprint":false},{"pmid":"35015684","id":"PMC_35015684","title":"BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.","date":"2022","source":"Blood cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35015684","citation_count":38,"is_preprint":false},{"pmid":"28331900","id":"PMC_28331900","title":"A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1.","date":"2017","source":"Gynecologic oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28331900","citation_count":34,"is_preprint":false},{"pmid":"34302054","id":"PMC_34302054","title":"Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.","date":"2021","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/34302054","citation_count":32,"is_preprint":false},{"pmid":"35499168","id":"PMC_35499168","title":"Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.","date":"2022","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35499168","citation_count":28,"is_preprint":false},{"pmid":"32376790","id":"PMC_32376790","title":"Human X chromosome exome sequencing identifies BCORL1 as contributor to spermatogenesis.","date":"2020","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32376790","citation_count":21,"is_preprint":false},{"pmid":"30941876","id":"PMC_30941876","title":"Variants in the transcriptional corepressor BCORL1 are associated with an X-linked disorder of intellectual disability, dysmorphic features, and behavioral abnormalities.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30941876","citation_count":20,"is_preprint":false},{"pmid":"29605720","id":"PMC_29605720","title":"Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells.","date":"2018","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29605720","citation_count":16,"is_preprint":false},{"pmid":"35596897","id":"PMC_35596897","title":"Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.","date":"2022","source":"Brain tumor pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35596897","citation_count":12,"is_preprint":false},{"pmid":"38216991","id":"PMC_38216991","title":"CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.","date":"2024","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/38216991","citation_count":8,"is_preprint":false},{"pmid":"33810051","id":"PMC_33810051","title":"Shukla-Vernon Syndrome: A Second Family with a Novel Variant in the BCORL1 Gene.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33810051","citation_count":7,"is_preprint":false},{"pmid":"36639698","id":"PMC_36639698","title":"Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling.","date":"2023","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36639698","citation_count":7,"is_preprint":false},{"pmid":"17697391","id":"PMC_17697391","title":"BCoR-L1 variation and breast cancer.","date":"2007","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/17697391","citation_count":6,"is_preprint":false},{"pmid":"38637838","id":"PMC_38637838","title":"BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.","date":"2024","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/38637838","citation_count":5,"is_preprint":false},{"pmid":"35838627","id":"PMC_35838627","title":"An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1.","date":"2022","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/35838627","citation_count":4,"is_preprint":false},{"pmid":"38342987","id":"PMC_38342987","title":"A hemizygous loss-of-function variant in BCORL1 is associated with male infertility and oligoasthenoteratozoospermia.","date":"2024","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38342987","citation_count":4,"is_preprint":false},{"pmid":"38995507","id":"PMC_38995507","title":"BCORL1, POF1B, and USP9X copy number variation in women with idiopathic diminished ovarian reserve.","date":"2024","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38995507","citation_count":3,"is_preprint":false},{"pmid":"40202539","id":"PMC_40202539","title":"Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients.","date":"2025","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/40202539","citation_count":2,"is_preprint":false},{"pmid":"40805145","id":"PMC_40805145","title":"BCOR, BCORL1, and BCL6 Mutations in Pediatric Leukemias.","date":"2025","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/40805145","citation_count":2,"is_preprint":false},{"pmid":"39189935","id":"PMC_39189935","title":"Novel and recurrent hemizygous variants in BCORL1 cause oligoasthenoteratozoospermia by interfering transcription.","date":"2024","source":"Andrology","url":"https://pubmed.ncbi.nlm.nih.gov/39189935","citation_count":1,"is_preprint":false},{"pmid":"36324816","id":"PMC_36324816","title":"BCORL1 S878G, GNB1 G116S, SH2B3 A536T, and KMT2D S3708R tetramutation co-contribute to a pediatric acute myeloid leukemia: Case report and literature review.","date":"2022","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/36324816","citation_count":1,"is_preprint":false},{"pmid":"32606114","id":"PMC_32606114","title":"Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations.","date":"2020","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/32606114","citation_count":1,"is_preprint":false},{"pmid":"32776737","id":"PMC_32776737","title":"Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.","date":"2020","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/32776737","citation_count":0,"is_preprint":false},{"pmid":"40466561","id":"PMC_40466561","title":"The association between XRCC2 and BCORL1 expression with sperm DNA fragmentation index in infertile men candidates undergoing intracytoplasmic sperm injection (ICSI).","date":"2025","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/40466561","citation_count":0,"is_preprint":false},{"pmid":"40724977","id":"PMC_40724977","title":"CNS Tumor with BCOR/BCORL1 Fusion: A Rare Tumor Entity.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40724977","citation_count":0,"is_preprint":false},{"pmid":"41787467","id":"PMC_41787467","title":"Epigenetic corepressor BCORL1 predominates as a driver of clonal hematopoiesis of indeterminate potential in patients undergoing chronic hemodialysis: a multicenter cohort study.","date":"2026","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/41787467","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18195,"output_tokens":2177,"usd":0.04362,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9104,"output_tokens":2631,"usd":0.055648,"stage2_stop_reason":"end_turn"},"total_usd":0.099268,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"BCORL1 (BCoR-L1) functions as a transcriptional corepressor that associates with Class II HDACs (HDAC4, HDAC5, HDAC7) as determined by co-precipitation, and interacts with the CtBP corepressor through a CtBP-interacting motif in its amino terminus.\",\n      \"method\": \"Co-precipitation, reporter assays, RNAi knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-precipitation, reporter assays, and RNAi knockdown with defined endogenous target (E-cadherin), multiple orthogonal methods in a single study\",\n      \"pmids\": [\"17379597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Abrogation of the CtBP binding site within BCORL1 partially relieves BCORL1-mediated transcriptional repression, demonstrating that CtBP interaction contributes to its repressor function. BCORL1 occupies the E-cadherin promoter and RNAi-mediated knockdown of BCORL1 derepresses E-cadherin in cells that normally silence it.\",\n      \"method\": \"Mutagenesis of CtBP-interacting motif, reporter assay, RNAi knockdown, ChIP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis combined with reporter assays and endogenous gene derepression by RNAi, multiple orthogonal methods\",\n      \"pmids\": [\"17379597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BCORL1 forms a heterodimer with PCGF1 and this BCORL1/PCGF1 heterodimer is required for recruitment of the non-canonical Polycomb Repressive Complex PRC1.1 to CpG islands via KDM2B/SKP1. The crystal structure of the KDM2B/SKP1/BCORL1/PCGF1 complex reveals that the BCORL1 PUFD domain positions residues preceding the RAWUL domain of PCGF1 to create an extended interface for KDM2B interaction.\",\n      \"method\": \"In vitro assembly assays, crystal structure, co-precipitation of subcomplexes\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with in vitro reconstitution of minimal complex and domain-level functional dissection\",\n      \"pmids\": [\"27568929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Mutations in BCORL1 (and BCOR) in leukemia disrupt assembly of the non-canonical PRC1.1 complex, selectively unlinking the RING-PCGF enzymatic core from the chromatin-targeting auxiliary subcomplex. Mutated PRC1.1 is localized to chromatin but lacks repressive H2A-ubiquitinating activity, leading to epigenetic reprogramming and transcriptional activation at target loci, and conferring acquired resistance to treatment while sensitizing to targeted kinase inhibition.\",\n      \"method\": \"Biochemical complex assembly assays, chromatin localization studies, transcriptomic analysis of mutant cells and primary patient samples\",\n      \"journal\": \"Blood cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complex assembly and chromatin localization experiments combined with transcriptomic data in mutant cells and primary samples, multiple orthogonal methods\",\n      \"pmids\": [\"35015684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Knockout of Bcorl1 in mice results in male infertility with impaired spermatogenesis, reduced sperm motility, and abnormal mitochondrial structure in sperm cells. Knockdown of Bcorl1 in mouse spermatogonial stem cells inhibits their self-renewal in vitro.\",\n      \"method\": \"CRISPR-Cas9 knockout mice, siRNA knockdown in spermatogonial stem cells\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR knockout mouse model with defined spermatogenic phenotype plus in vitro stem cell knockdown, two orthogonal approaches in one study\",\n      \"pmids\": [\"32376790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A truncating BCORL1 variant (p.Glu522*) produces a truncated protein with altered cellular localization and a dysfunctional interaction with SKP1 (S-phase kinase-associated protein 1), linking BCORL1 to the SCF ubiquitin ligase complex and to the pathogenesis of oligoasthenoteratozoospermia.\",\n      \"method\": \"Whole-exome sequencing, functional analysis with recombinant protein, localization assay, co-immunoprecipitation\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — single lab, co-IP and localization data for variant protein, limited replication\",\n      \"pmids\": [\"38342987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BCORL1 missense variants (p.V872G, p.G1391R) disrupt the interaction between BCORL1 and HDACs, causing epigenetic alterations and interfering with the orderly transcription of spermatogenetic genes, leading to OAT phenotype with acephalic sperm and abnormal acrosome.\",\n      \"method\": \"In vitro recombinant plasmid functional assays, co-immunoprecipitation, sperm morphology analysis\",\n      \"journal\": \"Andrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — single lab with in vitro functional assays and co-IP for HDAC interaction disruption, limited replication\",\n      \"pmids\": [\"39189935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A missense mutation BCORL1 Q1076H contributes to vemurafenib resistance in melanoma cells; either endogenous BCORL1 silencing or ectopic expression of BCORL1 Q1076H mimics the effects of CRISPR/Cas9-edited BCORL1 Q1076H, suggesting the mutation exerts a complex mixture of loss- and gain-of-function effects confirmed by transcriptomic data.\",\n      \"method\": \"CRISPR/Cas9 editing, RNAi silencing, ectopic overexpression, transcriptomics\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR editing, RNAi, and ectopic expression with transcriptomic validation, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"29605720\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCORL1 is a transcriptional corepressor that functions as a core subunit of the non-canonical Polycomb Repressive Complex PRC1.1: it forms a heterodimer with PCGF1 (via its PUFD domain) that recruits KDM2B/SKP1 to CpG islands for H2A ubiquitination and gene repression; it also associates with Class II HDACs (HDAC4/5/7) and the CtBP corepressor to silence target genes such as E-cadherin; loss-of-function mutations in leukemia unlink the PRC1.1 enzymatic core from its chromatin-targeting module, causing epigenetic reprogramming and oncogenic signaling; and in the germline, BCORL1 is required for spermatogenesis and spermatogonial stem cell self-renewal, with variants disrupting HDAC interaction and SKP1 binding.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BCORL1 is a transcriptional corepressor that silences target genes by coupling chromatin-targeting and histone-modifying machineries [#0, #2]. It associates with Class II histone deacetylases (HDAC4, HDAC5, HDAC7) and engages the CtBP corepressor through an amino-terminal CtBP-interacting motif; loss of CtBP binding partially relieves its repressive activity, and BCORL1 occupies and silences the E-cadherin promoter such that its depletion derepresses E-cadherin [#0, #1]. BCORL1 is a structural subunit of the non-canonical Polycomb Repressive Complex PRC1.1, where its PUFD domain heterodimerizes with PCGF1 to position residues preceding the PCGF1 RAWUL domain and build an extended interface that recruits KDM2B/SKP1 to CpG islands [#2]. In leukemia, BCORL1 mutations disrupt PRC1.1 assembly, unlinking the RING-PCGF enzymatic core from the chromatin-targeting subcomplex so that the complex remains chromatin-bound but loses H2A-ubiquitinating activity, driving epigenetic reprogramming and transcriptional activation at target loci [#3]. BCORL1 is required for male fertility: its knockout in mice impairs spermatogenesis, reduces sperm motility, and disrupts sperm mitochondrial structure, while knockdown blocks spermatogonial stem cell self-renewal, and human variants causing oligoasthenoteratozoospermia act by disrupting BCORL1 interactions with HDACs or with SKP1 [#4, #5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Established BCORL1's foundational identity as a transcriptional corepressor by defining its protein partners and a direct endogenous target, answering whether it actively silences genes.\",\n      \"evidence\": \"Co-precipitation with Class II HDACs and CtBP, mutagenesis of the CtBP motif, reporter assays, ChIP, and RNAi-mediated derepression of E-cadherin\",\n      \"pmids\": [\"17379597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether HDAC/CtBP association is direct or bridged\", \"Genome-wide target spectrum beyond E-cadherin not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined the structural basis for BCORL1's role in chromatin targeting, showing it is a core PRC1.1 subunit that heterodimerizes with PCGF1 to recruit KDM2B/SKP1 to CpG islands.\",\n      \"evidence\": \"In vitro complex reconstitution, co-precipitation of subcomplexes, and crystal structure of KDM2B/SKP1/BCORL1/PCGF1\",\n      \"pmids\": [\"27568929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how this module connects to the catalytic RING-PCGF core in cells\", \"In vivo CpG island occupancy not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected BCORL1 alteration to therapy resistance, showing a missense mutation modulates melanoma vemurafenib resistance through mixed loss- and gain-of-function effects.\",\n      \"evidence\": \"CRISPR/Cas9 editing, RNAi silencing, ectopic overexpression, and transcriptomics in melanoma cells\",\n      \"pmids\": [\"29605720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism linking the Q1076H mutation to resistance not resolved\", \"Whether effect operates through PRC1.1 or HDAC pathways unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed an in vivo physiological requirement for BCORL1 in male germline development, beyond its biochemical corepressor roles.\",\n      \"evidence\": \"CRISPR-Cas9 knockout mice with spermatogenic phenotyping and siRNA knockdown in spermatogonial stem cells\",\n      \"pmids\": [\"32376790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets driving the spermatogenesis defect not identified\", \"Link between corepressor activity and mitochondrial sperm phenotype unexplained\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved the mechanism by which leukemia mutations corrupt PRC1.1, showing they uncouple the enzymatic core from chromatin targeting while preserving chromatin localization.\",\n      \"evidence\": \"Biochemical complex assembly and chromatin localization assays plus transcriptomics of mutant cells and primary patient samples\",\n      \"pmids\": [\"35015684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific oncogenic target loci driving transformation not fully enumerated\", \"Mechanism of acquired drug resistance and kinase-inhibitor sensitization not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected specific human BCORL1 variants to oligoasthenoteratozoospermia by demonstrating disrupted SKP1 and HDAC interactions, tying germline pathology to its corepressor and SCF-linked interactions.\",\n      \"evidence\": \"Whole-exome sequencing, recombinant protein functional assays, localization assays, co-immunoprecipitation, and sperm morphology analysis\",\n      \"pmids\": [\"38342987\", \"39189935\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab co-IP data without reciprocal validation\", \"Causal link from interaction loss to specific sperm phenotypes not established in vivo\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BCORL1's corepressor functions (HDAC/CtBP association versus PRC1.1 assembly) are differentially deployed across tissues and which downstream gene programs they control in the germline remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide direct target catalog across cell types unknown\", \"Relative contributions of PRC1.1 versus HDAC/CtBP pathways to spermatogenesis undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"PRC1.1 (non-canonical PRC1)\"\n    ],\n    \"partners\": [\n      \"PCGF1\",\n      \"KDM2B\",\n      \"SKP1\",\n      \"HDAC4\",\n      \"HDAC5\",\n      \"HDAC7\",\n      \"CtBP\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}